Variant report

Variant	nsv883211
Chromosome Location	chr5:177787515-177820134
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:153)
CpG islands
(count:673)
Chromatin interactive
region (count:22)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:153 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:177801961-177802199	K562	blood:	n/a	n/a
2	CEBPB	chr5:177791758-177792149	MCF-7	breast:	n/a	chr5:177791997-177792010
3	CHD2	chr5:177811271-177811417	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD2	chr5:177807188-177807205	HepG2	liver:	n/a	n/a
5	CTCF	chr5:177818429-177818472	LNCaP	prostate:	n/a	n/a
6	CTCF	chr5:177795480-177795630	NB4	blood:	n/a	n/a
7	CTCF	chr5:177801940-177802090	K562	blood:	n/a	n/a
8	CTCF	chr5:177812060-177812210	HL-60	blood:	n/a	n/a
9	CTCF	chr5:177818054-177818127	MCF-7	breast:	n/a	n/a
10	CTCF	chr5:177801700-177801850	MCF-7	breast:	n/a	n/a
11	CTCF	chr5:177801924-177802130	MCF-7	breast:	n/a	n/a
12	CTCF	chr5:177818572-177818621	GM10266	blood:	n/a	n/a
13	CTCF	chr5:177801994-177802084	MCF-7	breast:	n/a	n/a
14	CTCF	chr5:177801987-177802094	MCF-7	breast:	n/a	n/a
15	CTCF	chr5:177801985-177802101	MCF-7	breast:	n/a	n/a
16	CTCF	chr5:177816400-177816550	SK-N-SH_RA	brain:	n/a	n/a
17	CTCF	chr5:177812020-177812170	GM12865	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
18	CTCF	chr5:177802005-177802053	Hela-S3	cervix:	n/a	n/a
19	CTCF	chr5:177801907-177802119	K562	blood:	n/a	n/a
20	CTCF	chr5:177818040-177818101	MCF-7	breast:	n/a	n/a
21	CTCF	chr5:177812000-177812150	GM12864	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
22	CTCF	chr5:177801840-177802190	K562	blood:	n/a	n/a
23	CTCF	chr5:177811980-177812130	SK-N-SH_RA	brain:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
24	CTCF	chr5:177801860-177802010	HepG2	liver:	n/a	n/a
25	CTCF	chr5:177801860-177802010	MCF-7	breast:	n/a	n/a
26	CTCF	chr5:177795440-177795590	HepG2	liver:	n/a	n/a
27	CTCF	chr5:177801863-177802144	T-47D	breast:	n/a	n/a
28	CTCF	chr5:177801940-177802122	MCF-7	breast:	n/a	n/a
29	CTCF	chr5:177818018-177818107	MCF-7	breast:	n/a	n/a
30	CTCF	chr5:177795560-177795710	K562	blood:	n/a	n/a
31	CTCF	chr5:177818027-177818131	MCF-7	breast:	n/a	n/a
32	CTCF	chr5:177818043-177818110	LNCaP	prostate:	n/a	n/a
33	CTCF	chr5:177811999-177812127	H1-hESC	embryonic stem cell:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
34	CTCF	chr5:177801940-177802090	MCF-7	breast:	n/a	n/a
35	CTCF	chr5:177792140-177792290	SK-N-SH_RA	brain:	n/a	n/a
36	CTCF	chr5:177806840-177806990	GM12868	blood:	n/a	n/a
37	CTCF	chr5:177818069-177818101	LNCaP	prostate:	n/a	n/a
38	CTCF	chr5:177812020-177812170	HEK293	kidney:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
39	CTCF	chr5:177807080-177807230	GM12868	blood:	n/a	n/a
40	CTCF	chr5:177811920-177812070	GM06990	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
41	CTCF	chr5:177811980-177812130	WERI-Rb-1	eye:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
42	CTCF	chr5:177802000-177802046	HepG2	liver:	n/a	n/a
43	CTCF	chr5:177801806-177802224	MCF-7	breast:	n/a	n/a
44	CTCF	chr5:177801991-177802042	GM12878	blood:	n/a	n/a
45	E2F4	chr5:177798200-177798400	MCF10A-Er-Src	breast:	n/a	n/a
46	E2F6	chr5:177811192-177811338	K562	blood:	n/a	n/a
47	EBF1	chr5:177808953-177809280	GM12878	blood:	n/a	chr5:177809130-177809139 chr5:177809128-177809141
48	EP300	chr5:177811282-177811289	K562	blood:	n/a	n/a
49	EP300	chr5:177815861-177817068	SK-N-SH	brain:	n/a	n/a
50	EP300	chr5:177816288-177816737	SK-N-SH_RA	brain:	n/a	n/a

(count:673 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:177819485-177819535	Caco-2	colon:	n/a
2	chr5:177811198-177811248	SK-N-MC	brain:	n/a
3	chr5:177819485-177819535	Caco-2	colon:	n/a
4	chr5:177811198-177811248	SK-N-MC	brain:	n/a
5	chr5:177799205-177799255	A549	lung:	n/a
6	chr5:177811648-177811698	IMR90	lung:	fetal
7	chr5:177799357-177799407	H1-hESC	embryonic stem cell:	embryo
8	chr5:177790659-177790709	GM06990	blood:	n/a
9	chr5:177810294-177810344	NH-A	brain:	n/a
10	chr5:177811198-177811248	GM06990	blood:	n/a
11	chr5:177809164-177809214	U87	brain:	n/a
12	chr5:177799205-177799255	LNCaP	prostate:	n/a
13	chr5:177799357-177799407	SAEC	small airway:	n/a
14	chr5:177814702-177814752	HCF	heart:	n/a
15	chr5:177819485-177819535	AG10803	skin:	n/a
16	chr5:177811648-177811698	HRE	kidney:	n/a
17	chr5:177810294-177810344	GM12892	blood:	n/a
18	chr5:177799357-177799407	ECC-1	luminal epithelium:	n/a
19	chr5:177811198-177811248	AG04450	lung:	fetal
20	chr5:177819485-177819535	AG04449	skin:	fetal
21	chr5:177819485-177819535	HRE	kidney:	n/a
22	chr5:177811349-177811399	PFSK-1	brain:	n/a
23	chr5:177799357-177799407	HepG2	liver:	n/a
24	chr5:177811648-177811698	HAEpiC	amniotic membrane:	n/a
25	chr5:177810294-177810344	HCT-116	colon:	n/a
26	chr5:177805003-177805053	HNPCEpiC	eye:	n/a
27	chr5:177799357-177799407	NT2-D1	testis:	n/a
28	chr5:177810294-177810344	IMR90	lung:	fetal
29	chr5:177819485-177819535	HepG2	liver:	n/a
30	chr5:177811349-177811399	HPAEpiC	pulmonary alveolar:	n/a
31	chr5:177790659-177790709	H1-hESC	embryonic stem cell:	embryo
32	chr5:177810294-177810344	T-47D	breast:	n/a
33	chr5:177811349-177811399	ovcar-3	ovarian:	n/a
34	chr5:177799357-177799407	AoSMC	blood vessel:	n/a
35	chr5:177805003-177805053	HCF	heart:	n/a
36	chr5:177799205-177799255	HUVEC	blood vessel:	n/a
37	chr5:177790659-177790709	GM19239	blood:	n/a
38	chr5:177799205-177799255	HRCEpiC	kidney:	n/a
39	chr5:177799205-177799255	HAEpiC	amniotic membrane:	n/a
40	chr5:177810294-177810344	HCM	heart:	n/a
41	chr5:177811349-177811399	HEEpiC	esophagus:	n/a
42	chr5:177811648-177811698	T-47D	breast:	n/a
43	chr5:177811349-177811399	U87	brain:	n/a
44	chr5:177799205-177799255	T-47D	breast:	n/a
45	chr5:177811648-177811698	PANC-1	pancreas:	n/a
46	chr5:177799205-177799255	HL-60	blood:	n/a
47	chr5:177811648-177811698	MCF10A-Er-Src	breast:	n/a
48	chr5:177790659-177790709	A549	lung:	n/a
49	chr5:177790659-177790709	SK-N-SH_RA	brain:	n/a
50	chr5:177799205-177799255	AG09319	gingival:	n/a

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:177806047..177808844-chr5:177816962..177819431,2	K562	blood:
2	chr5:177816543..177819082-chr5:177820341..177823036,2	K562	blood:
3	chr5:177790380..177792280-chr5:177796021..177798764,2	K562	blood:
4	chr5:177808919..177811059-chr5:177815128..177817359,2	K562	blood:
5	chr5:177799370..177801920-chr5:177806975..177809019,2	MCF-7	breast:
6	chr5:177804849..177806989-chr5:177807066..177809838,2	MCF-7	breast:
7	chr5:177808919..177811059-chr5:177815128..177817359,2	K562	blood:
8	chr5:177811102..177814167-chr5:177815792..177819406,4	K562	blood:
9	chr5:177811102..177812638-chr5:177817501..177819406,2	K562	blood:
10	chr5:177811102..177812638-chr5:177817501..177819406,2	K562	blood:
11	chr5:177793010..177795271-chr5:177803266..177804910,2	K562	blood:
12	chr5:177799370..177801920-chr5:177806975..177809019,2	MCF-7	breast:
13	chr5:177786537..177789455-chr5:177802501..177804616,2	K562	blood:
14	chr5:177786537..177789455-chr5:177802501..177804616,2	K562	blood:
15	chr5:177790380..177792280-chr5:177796021..177798764,2	K562	blood:
16	chr5:177777429..177779459-chr5:177792254..177794069,2	MCF-7	breast:
17	chr5:177793010..177795271-chr5:177803266..177804910,2	K562	blood:
18	chr5:177775759..177777700-chr5:177785151..177787817,3	K562	blood:
19	chr5:177806047..177808844-chr5:177816962..177819431,2	K562	blood:
20	chr5:177811102..177814167-chr5:177815792..177819406,4	K562	blood:
21	chr5:177804316..177806496-chr5:177806617..177809077,2	K562	blood:
22	chr5:177784139..177785777-chr5:177788896..177791858,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HNRNPAB-6	chr5:177804925-177805219	NONHSAT105532

No data

Variant related genes	Relation type
RN7SL646P	TF binding region
RN7SL646P	CpG island
ENSG00000253698	chromatin interactions
ENSG00000242341	chromatin interactions

Extended variants
information (count: 1624 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:1624 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7729589	chr5:177787515-177787516	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs532741818	chr5:177787516-177787517	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs553756250	chr5:177787533-177787534	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs551146570	chr5:177787537-177787538	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs145484734	chr5:177787539-177787540	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs530321342	chr5:177787554-177787555	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs548281898	chr5:177787572-177787573	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs551013025	chr5:177787576-177787577	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs141413582	chr5:177787670-177787671	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs545520649	chr5:177787678-177787679	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs556256078	chr5:177787707-177787708	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs552227885	chr5:177787708-177787709	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs555818969	chr5:177787709-177787710	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs570753455	chr5:177787711-177787712	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs537789676	chr5:177787712-177787713	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs556429982	chr5:177787714-177787715	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs559933489	chr5:177787716-177787717	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs568115756	chr5:177787717-177787718	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs570918932	chr5:177787722-177787723	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs535660370	chr5:177787739-177787740	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs368599450	chr5:177787763-177787764	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs147018466	chr5:177787770-177787771	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs573029707	chr5:177787803-177787804	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs540230706	chr5:177787814-177787815	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs558570381	chr5:177787832-177787833	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs577180403	chr5:177787841-177787842	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs537090362	chr5:177787842-177787843	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs138213693	chr5:177787865-177787866	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs374872535	chr5:177787879-177787880	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs143601657	chr5:177787899-177787900	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs530202337	chr5:177787936-177787937	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs369329832	chr5:177787939-177787940	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs560265814	chr5:177788002-177788003	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs143134351	chr5:177788010-177788011	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs552191172	chr5:177788022-177788023	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs570310359	chr5:177788028-177788029	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs531338960	chr5:177788034-177788035	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs531328664	chr5:177788129-177788130	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs184952081	chr5:177788136-177788137	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs568359678	chr5:177788178-177788179	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs535250833	chr5:177788214-177788215	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs553597563	chr5:177788216-177788217	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs372022417	chr5:177788230-177788231	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs566618341	chr5:177788297-177788298	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs533989987	chr5:177788300-177788301	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs558630912	chr5:177788321-177788322	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs189356891	chr5:177788324-177788325	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs181012239	chr5:177788344-177788345	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs186145510	chr5:177788395-177788396	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs113877557	chr5:177788413-177788414	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:508 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177783800-177788400	Weak transcription	HSMMtube	muscle
2	chr5:177784400-177787600	Weak transcription	Spleen	Spleen
3	chr5:177784400-177787800	Weak transcription	Pancreas	Pancrea
4	chr5:177784400-177790800	Weak transcription	Lung	lung
5	chr5:177784400-177796800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr5:177784400-177798200	Weak transcription	Right Atrium	heart
7	chr5:177784600-177787800	Weak transcription	Fetal Thymus	thymus
8	chr5:177784600-177788600	Weak transcription	Thymus	Thymus
9	chr5:177784600-177789200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr5:177784600-177790800	Weak transcription	Placenta	Placenta
11	chr5:177784800-177788400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr5:177784800-177788800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr5:177785000-177789200	Weak transcription	HUES48 Cell Line	embryonic stem cell
14	chr5:177785200-177792000	Weak transcription	HUES6 Cell Line	embryonic stem cell
15	chr5:177785200-177798200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr5:177785600-177792200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr5:177786200-177789800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
18	chr5:177786600-177788000	Bivalent Enhancer	Fetal Muscle Leg	muscle
19	chr5:177786600-177788400	Enhancers	Cortex derived primary cultured neurospheres	brain
20	chr5:177786800-177787600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr5:177786800-177787800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr5:177786800-177787800	Bivalent Enhancer	Fetal Stomach	stomach
23	chr5:177786800-177787800	Enhancers	NHDF-Ad	bronchial
24	chr5:177786800-177789400	Enhancers	H1 Cell Line	embryonic stem cell
25	chr5:177787000-177791800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
26	chr5:177787200-177788000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr5:177787200-177788800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
28	chr5:177787200-177790800	Weak transcription	Monocytes-CD14+_RO01746	blood
29	chr5:177787200-177798200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr5:177787400-177790800	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr5:177787600-177788000	Enhancers	Spleen	Spleen
32	chr5:177787800-177788000	Enhancers	Pancreas	Pancrea
33	chr5:177787800-177788200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
34	chr5:177787800-177788200	Weak transcription	NHDF-Ad	bronchial
35	chr5:177787800-177789200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
36	chr5:177787800-177789800	Enhancers	Fetal Thymus	thymus
37	chr5:177788000-177788400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr5:177788000-177788800	Weak transcription	Spleen	Spleen
39	chr5:177788200-177789200	Enhancers	NHDF-Ad	bronchial
40	chr5:177788200-177789400	Bivalent Enhancer	Fetal Muscle Leg	muscle
41	chr5:177788200-177789600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr5:177788400-177789200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr5:177788400-177789400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr5:177788400-177790800	Weak transcription	Cortex derived primary cultured neurospheres	brain
45	chr5:177788400-177790800	Enhancers	HSMMtube	muscle
46	chr5:177788600-177788800	Bivalent Enhancer	Fetal Stomach	stomach
47	chr5:177788600-177788800	Enhancers	Thymus	Thymus
48	chr5:177788600-177789200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr5:177788600-177789200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr5:177788800-177789000	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links